GlobalData on MSN
FDA accepts Beren Therapeutics’ NDA for Niemann-Pick disease
The submission includes data indicating a meaningful survival benefit for infantile-onset NPC patients treated with adrabetadex.
The NDA is based on results from the Phase III evERA Breast Cancer study. Credit: NMK-Studio / Shutterstock.com. (NMK-Studio / Shutterstock.com.) Roche has obtained acceptance from the US Food and ...
Zacks Investment Research on MSN
FDA accepts Roche's NDA seeking approval for breast cancer drug
Roche RHHBY announced that the FDA has accepted its new drug application (NDA) for giredestrant, an investigational oral ...
Using proprietary copolymer technology, TEV-’749 allows for a controlled steady release of olanzapine, a second generation antipsychotic.
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best value stocks to buy now. On February 17, Bristol Myers Squibb announced that the FDA accepted its NDA for iberdomide, which is an ...
The Barstool Sports personality appeared on Logan Paul’s “Impaulsive” podcast and dubbed Bryan’s relationship with his wife a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results